BDSX

Biodesix, Inc. (NASDAQ:BDSX) is a data-driven diagnostic solutions company founded in 2005 and headquartered in Boulder, Colorado. Originally incorporated as Elston Technologies, Inc., the company went public in October 2020. Biodesix specializes in blood-based diagnostic tests for lung disease, particularly focusing on lung cancer risk assessment and treatment guidance. The company has evolved from a research-focused organization into a commercial-stage diagnostics company with a growing sales force and expanding test portfolio.